IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $36,000 | -89.8% | 10,100 | -29.2% | 0.00% | -81.8% |
| Q3 2021 | $352,000 | +60.0% | 14,264 | -79.0% | 0.01% | +57.1% |
| Q2 2021 | $220,000 | +12.8% | 67,800 | -62.2% | 0.01% | -36.4% |
| Q1 2021 | $195,000 | -89.7% | 179,600 | -33.6% | 0.01% | -79.6% |
| Q4 2020 | $1,885,000 | +4497.6% | 270,300 | +1444.6% | 0.05% | +2600.0% |
| Q3 2020 | $41,000 | +173.3% | 17,500 | -8.9% | 0.00% | +100.0% |
| Q2 2020 | $15,000 | -96.8% | 19,200 | -77.6% | 0.00% | -96.8% |
| Q1 2020 | $465,000 | +87.5% | 85,600 | +19.7% | 0.03% | +121.4% |
| Q4 2019 | $248,000 | +1205.3% | 71,500 | +42.7% | 0.01% | +1300.0% |
| Q1 2018 | $19,000 | – | 50,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |